Related Experiment Videos
Glycogenosis type IB: possible membrane transport defect
Insights
A 20-month-old child presented with glycogen storage disease type IB. Further studies suggest a specific glucose-6-phosphate transport defect, not a deficiency in the enzyme itself.
Area of Science:
- Biochemistry
- Pediatric Endocrinology
- Metabolic Disorders
Background:
- Glycogen storage diseases (GSDs) are inherited metabolic disorders affecting glycogen synthesis or degradation.
- Type IB glycogen storage disease is characterized by a deficiency in the glucose-6-phosphate transporter (G6PT).
- This leads to impaired glucose release from the liver and hypoglycemia.
Observation:
- A 20-month-old child exhibited clinical and biochemical features consistent with glycogen storage disease type IB.
- Functional testing mirrored glucose-6-phosphatase deficiency.
- In vitro studies revealed normal hepatic glucose-6-phosphatase activity in the patient's liver tissue.
Findings:
- Disruption of liver cell membranes with deoxycholic acid increased glucose-6-phosphatase activity.
- This suggests an enzyme "latency" phenomenon rather than a complete deficiency.
- The findings point towards a defect in glucose-6-phosphate transport (G6PT deficiency).
Implications:
- This case supports glycogen storage disease type IB as a distinct entity.
- It highlights the importance of differentiating transport defects from enzyme deficiencies in GSDs.
- Further research into glucose-6-phosphate transport mechanisms is warranted.
Abstract:
We have described a 20-month-old child with type IB glycogen storage disease, based on clinical and biochemical manifestations. Functional testing data were similar to those found in glucose-6-phosphatase deficiency, but in vitro studies showed normal hepatic glucose-6-phosphatase activity. Disruption of membranes with deoxycholic acid was followed by an increase in enzyme activity compared to a control liver tissue, suggesting "latency" of enzyme. We suggest that this patient had glycogen storage type IB and that this disorder may represent a specific glucose-6-phosphate transport defect.